https://www.selleckchem.com/
ing a diagnosis of AMD. Biomarkers of AMD may be used to monitor disease risk, response to treatment and disease progression. Biomarkers of AMD may be used to monitor disease risk, response to treatment and disease progression. To investigate the retinal vessel density (VD) in healthy and normal-tension glaucoma (NTG) eyes through optical coherence tomography angiography (OCTA) and to determine the correlation between VD and the retinal nerve fiber layer (RNFL) thickness and functional visual field (VF) defects for different locations. A total of 74 NTG eye
Like
Comment
Share
